4//SEC Filing
Aberman Zami 4
Accession 0001213900-20-026069
CIK 0001158780other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 4:46 PM ET
Size
7.9 KB
Accession
0001213900-20-026069
Insider Transaction Report
Form 4
Aberman Zami
DirectorCEO & Co. Chairman
Transactions
- Award
Restricted Stock Units
2020-09-10+500,000→ 993,973 total - Award
Restricted Stock Units
2020-09-10+500,000→ 1,493,973 total
Holdings
- 11,140(indirect: By Rose Hitech Ltd.)
Common Stock
Footnotes (4)
- [F1]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter.
- [F3]The shares vest in full upon milestone achievement of increasing market capitalization of the Issuer's common stock on the Nasdaq Capital Market to $550 million within no more than 3 years from the date of grant.
- [F4]Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019.
Documents
Issuer
PLURISTEM THERAPEUTICS INC
CIK 0001158780
Entity typeother
Related Parties
1- filerCIK 0001344740
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 4:46 PM ET
- Size
- 7.9 KB